NCT00851578View on ClinicalTrials.gov

ASA Plavix Feasibility Study With WATCHMAN Left Atrial Appendage Closure Technology

NACompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

February 29, 2012

Study Completion Date

December 31, 2013

Conditions
Atrial Fibrillation
Interventions
DEVICE

WATCHMAN

WATCHMAN LAA Closure Device

Trial Locations (4)

60389

Sankt Katharinen Hospital / Cardiovasculares Centrum, Frankfurt

93049

Chefarzt der Medizinischen Klinik III/Kardiologie, Regensburg

150 30

NA Homolce Hospital, Prague

04289

Herzzentrum Leipzig, Leipzig

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY